ArticleCancer medicine2020

The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitors.

Barry Paul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.